Sharon Avkin-Nahum

Title: **Innovations by Sharon Avkin-Nahum: A Trailblazer in Fibrosis Treatment**

Introduction

Sharon Avkin-Nahum, an accomplished inventor based in Nes Ziona, Israel, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of five patents, her innovative work primarily focuses on methods for treating fibrotic diseases.

Latest Patents

Sharon's latest patents demonstrate her commitment to advancing medical treatments. One of her notable inventions is a method for treating fibrosis using siRNA and a retinoid-lipid drug carrier. This involved developing a pharmaceutical composition that combines a lipid and a retinoid along with a double-stranded nucleic acid molecule comprising an antisense sequence targeting mRNA encoding human hsp47. The second similar patent explores a pharmaceutical composition for treating fibrotic diseases under similar methodologies, further showcasing her expertise in this critical area of research.

Career Highlights

Sharon is associated with the Nitto Denko Corporation, a company known for its pioneering developments in various technological sectors. Her role there allows her to engage in cutting-edge research and collaborate with some of the brightest minds in the field.

Collaborations

Throughout her career, Sharon has collaborated with esteemed colleagues, including Yoshiro Niitsu and Victor Knopov. These collaborations have not only enriched her research but also contributed to the advancement of therapeutic techniques for managing fibrotic conditions.

Conclusion

Sharon Avkin-Nahum's innovative approaches to treating fibrosis highlight her dedication to improving patient outcomes through scientific research. As she continues her work at Nitto Denko Corporation, her contributions will undoubtedly pave the way for future advancements in medical science.